Utah Medical Products, Inc. (UTMD)
- Previous Close
70.45 - Open
70.64 - Bid 69.08 x 100
- Ask 69.80 x 300
- Day's Range
69.22 - 70.64 - 52 Week Range
65.91 - 100.59 - Volume
8,412 - Avg. Volume
29,666 - Market Cap (intraday)
246.002M - Beta (5Y Monthly) 0.15
- PE Ratio (TTM)
15.49 - EPS (TTM)
4.50 - Earnings Date Jul 23, 2024 - Jul 29, 2024
- Forward Dividend & Yield 1.20 (1.72%)
- Ex-Dividend Date Jun 14, 2024
- 1y Target Est
--
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
www.utahmed.comRecent News: UTMD
Performance Overview: UTMD
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UTMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UTMD
Valuation Measures
Market Cap
246.00M
Enterprise Value
152.48M
Trailing P/E
15.49
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.16
Price/Book (mrq)
1.93
Enterprise Value/Revenue
3.11
Enterprise Value/EBITDA
6.98
Financial Highlights
Profitability and Income Statement
Profit Margin
33.39%
Return on Assets (ttm)
8.65%
Return on Equity (ttm)
13.33%
Revenue (ttm)
49.04M
Net Income Avi to Common (ttm)
16.38M
Diluted EPS (ttm)
4.50
Balance Sheet and Cash Flow
Total Cash (mrq)
93.81M
Total Debt/Equity (mrq)
0.22%
Levered Free Cash Flow (ttm)
16.57M
Research Analysis: UTMD
Company Insights: UTMD
UTMD does not have Company Insights